High-Throughput Screen Detects Calcium Signaling Dysfunction in Hutchinson-Gilford Progeria Syndrome.

Area of Science:

• Genetics and Molecular Biology
• Cellular Biology
• Pathophysiology

Background:

• Hutchinson-Gilford progeria syndrome (HGPS) is a rare, fatal childhood disorder characterized by rapid aging.
• It results from a dominant mutation in the LMNA gene.
• Understanding HGPS molecular pathways is crucial for developing effective treatments.

Purpose of the Study:

• To identify novel molecular pathways affected in HGPS.
• To investigate the role of calcium signaling in HGPS pathogenesis.
• To explore potential therapeutic strategies for HGPS.

Main Methods:

• Next-generation sequencing (NGS) of HGPS and healthy cell lines.
• Differential gene expression analysis.
• Western blot, calcium imaging (FlexStation 3), flow cytometry for ROS and apoptosis.

Main Results:

• Nine hundred and eleven transcripts were differentially expressed between HGPS and healthy cells.
• Genes linked to calcium signaling (ITPR1, ITPR3, CACNA2D1, CAMK2N1) were significantly altered.
• HGPS cells exhibited higher basal intracellular Ca2+ and increased ROS production, linking Ca2+ signaling to ROS in HGPS.

Conclusions:

• The calcium signaling pathway is significantly altered in HGPS, partly due to ROS overproduction.
• These findings highlight a potential therapeutic window for HGPS treatment.
• The study opens new avenues for researching accelerated and healthy aging processes.